Pandemic Science Hub to develop better drugs to fight lung disease
New, multi-million pound research programme at the University of Edinburgh will develop treatments for lung infections
Our agile response to the pandemic and early support for ground breaking projects such as #STOPCOVID have laid the… https://t.co/vL0BBvlAsj
Action Medical Research and LifeArc announce another round of funding to support translational research into children’s rare diseases
£1m fund to progress promising translational research addressing a medical need for children and young people
LifeArc and Scottish Government work together to drive Scottish research into rare diseases
LifeArc and the Chief Scientist Office (CSO) for the Scottish Government have today jointly awarded a total…
Study reveals gene faults underpinning severe Covid-19
The study paves the way for new tests and treatments to protect people from infection.
LifeArc elects new Board Chair to drive charity’s ambitious strategy
Dr Ian Gilham appointed new Chair of Trustees to succeed Dr John Stageman when he steps down on 4 April after eight years.
New study explores unique approach to treat a rare liver disease
A research study looking into a new approach to treat primary sclerosing cholangitis (PSC) is progressing to clinical trials.
LifeArc bolsters scientific leadership by appointing new Chief Scientific Officer
Welcome to Dr Dave Powell, who has joined LifeArc as our first Chief Scientific Officer (CSO). Dave is an experienced scientist and leader, with…
LifeArc appoints first Chief Operating Officer
Richard Godfrey has joined LifeArc as its first Chief Operating Officer (COO). The new role will strengthen…
LifeArc participates in Series A funding round for company developing pioneering new gene therapies for neurodegenerative diseases
Helping to progress an innovative gene therapy platform from the bench to a stage where it is progressing closer to the clinic.